RNA Therapy

Jan. 30, 2025

In recent days RNA-based precision therapeutics are emerging as a game-changer for genetic disorders, including inherited retinal diseases (IRDs).

About RNA Therapy:

  • It is a term used to describe the use of RNA-based molecules to modulate biological pathways to cure a specific condition. 
  • Unlike gene-editing therapies, RNA-based therapies offer a safer alternative as they make temporary changes that do not carry over to future generations, reducing the risk of unintended long-term effects.

Applications of RNA based Therapies:

  • RNA-editing with ADAR enzymes: It can correct specific genetic mutations at the RNA level. This method has the potential to restore protein production in retinal cells without altering the underlying DNA, offering a new way to treat retinal degenerative diseases caused by single-point mutations.
  • Using of suppressor tRNAs: It is to bypass stop-codon mutations, which can prematurely halt protein synthesis in retinal cells. By enabling the production of full-length proteins, this approach could help restore proper retinal function in IRD patients.
  • PTC124 Method: It is also known as ataluren, which is already being used to treat patients with cystic fibrosis and Duchenne muscular dystrophy. 
  • Antisense oligonucleotides (ASOs) have already been used successfully to treat diseases such as spinal muscular atrophy and Duchenne muscular dystrophy.

Latest Current Affairs

See All

Enquire Now